Skip to main content
Livermore
Livermore
ZHEN

First Nebraska Trust Co

SEC CIK
0002134841
Latest filing
Aug 12, 2026

ABT holding history

Abbott Laboratories in every 13F filed by First Nebraska Trust Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
6,009
Value
$545.3K
% of portfolio
<0.1%
Quarters held
53
Since Q2 2001
Holdings of ABT by First Nebraska Trust Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,009$545.3K<0.1%+50+0.8%AddedHolders
Q1 20265,959$611.8K0.1%−25−0.4%ReducedHolders
Q4 20255,984$749.7K0.1%00.0%UnchangedHolders
Q3 20255,984$801.5K0.1%00.0%UnchangedHolders
Q2 20255,984$824.1K0.1%−75−1.2%ReducedHolders
Q1 20256,059$803.7K0.1%00.0%UnchangedHolders
Q4 20246,059$685.3K0.1%00.0%UnchangedHolders
Q3 20246,059$690.8K0.1%−104−1.7%ReducedHolders
Q2 20246,163$640.4K0.1%00.0%UnchangedHolders
Q1 20246,163$700.5K0.1%+362+6.2%AddedHolders
Q4 20235,801$638.5K0.1%+57+1.0%AddedHolders
Q3 20235,744$556.3K0.1%00.0%UnchangedHolders
Q2 20235,744$626.2K0.1%00.0%UnchangedHolders
Q1 20235,744$581.6K0.1%00.0%UnchangedHolders
Q4 20225,744$630.6K0.1%−25−0.4%ReducedHolders
Q3 20225,769$558.2K0.1%00.0%UnchangedHolders
Q2 20225,769$626.8K0.1%00.0%UnchangedHolders
Q1 20225,769$682.8K0.1%00.0%UnchangedHolders
Q4 20215,769$811.9K0.1%−1,000−14.8%ReducedHolders
Q3 20216,769$799.6K0.1%00.0%UnchangedHolders
Q2 20216,769$784.7K0.1%00.0%UnchangedHolders
Q1 20216,769$811.2K0.1%–No prior filingHolders
Q3 2020––––Not filed–
Q2 20209,898$905.0K0.2%00.0%Unchanged–
Q1 20209,898$781.1K0.2%+5,829+143.3%Added–
Q4 20194,069$353.4K0.1%00.0%Unchanged–
Q3 20194,069$340.5K0.1%+233+6.1%Added–
Q2 20193,836$322.6K0.1%00.0%Unchanged–
Q1 20193,836$306.6K0.1%00.0%Unchanged–
Q4 20183,836$277.5K0.1%+50+1.3%Added–
Q3 20183,786$277.7K<0.1%−102−2.6%Reduced–
Q2 20183,888$237.1K0.1%−179−4.4%Reduced–
Q1 20184,067$243.7K<0.1%−100−2.4%Reduced–
Q4 20174,167$237.8K<0.1%−9−0.2%Reduced–
Q3 20174,176$222.8K<0.1%00.0%Unchanged–
Q2 20174,176$203.0K<0.1%+4,176New–
Q4 20160$00.0%−5,199−100.0%Sold out–
Q3 20165,199$219.9K0.1%+5,199New–
Q2 20160$00.0%−5,076−100.0%Sold out–
Q1 20165,076$212.3K0.1%00.0%Unchanged–
Q4 20155,076$228.0K0.1%+5,076New–
Q3 20150$00.0%−4,230−100.0%Sold out–
Q2 20154,230$207.6K0.1%+4,230New–
Q1 20150$00.0%−5,230−100.0%Sold out–
Q4 20145,230$235.5K0.1%00.0%Unchanged–
Q3 20145,230$217.5K0.1%00.0%Unchanged–
Q2 20145,230$213.9K0.1%−300−5.4%Reduced–
Q1 20145,530$213.0K0.1%+165+3.1%Added–
Q4 20135,365$205.6K0.1%+5,365New–
Q1 20130$00.0%−5,151−100.0%Sold out–
Q4 20125,151$337.4K0.1%+300+6.2%Added–
Q3 20124,851$332.6K0.1%00.0%Unchanged–
Q2 20124,851$312.7K0.1%00.0%Unchanged–
Q1 20124,851$297.3K0.1%00.0%Unchanged–
Q4 20114,851$272.8K0.1%+4,851New–
Q2 20020$00.0%−4,200−100.0%Sold out–
Q1 20024,200$220.9K0.1%00.0%Unchanged–
Q4 20014,200$234.2K0.1%00.0%Unchanged–
Q3 20014,200$217.8K0.1%00.0%Unchanged–
Q2 20014,200$201.6K0.1%+4,200New–